Thousands of contaminated or potentially tainted medications have made it to market over the past year after laboratories responsible for testing custom-made pharmaceutical products failed to follow proper procedures, FDA records show.
The Food and Drug Administration uncovered the problems during a series of surprise inspections at dozens of specialty pharmacies over the past year, prompted by last fall’s deadly meningitis outbreak tied to tainted steroid injections made by one of the pharmacies, New England Compounding Center (NECC).
